[Prophylactic immunocorrection with sodium nucleinate].
Zemskov
A M
AM
Zemskov
V M
VM
Kuralesin
N A
NA
Mikhaĭlov
A A
AA
Snopkova
V A
VA
Abdulina
G A
GA
Evstratov
Iu A
IuA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001427:Bacterial Toxins; D003016:Clostridium perfringens; D004195:Disease Models, Animal; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006168:Guinea Pigs; D006801:Humans; D007154:Immune System Diseases / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D007623:Kazakhstan; D051379:Mice; D009696:Nucleic Acids / Q000627:therapeutic use*; D009784:Occupational Diseases / Q000276:immunology / Q000517:prevention & control; D010578:Petroleum; D012426:Russia
D000276:Adjuvants, Immunologic; D001427:Bacterial Toxins; D009696:Nucleic Acids; D010578:Petroleum; C013683:sodium nucleinate